Plunkett Research Online: Hemispherx Biopharma Inc

HEMISPHERX BIOPHARMA INC (HEB:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Hemispherx Biopharma, Inc. is a specialty pharmaceutical company engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. The company's proprietary drug technology uses specifically configu.....



Hemispherx Biopharma Inc
Ticker: HEB
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 215 988-0080
Fax: 215 988-1739
Address: 860 North Orange Avenue
Suite B
Orlando, FL 32801 United States

Types Of Business
Industry Ranks

Industry NAICS code:

RNA-Related Drugs
HIV Treatments
Antivirals
ContactsDescription
Thomas EquelsCEO/Director/President/Vice Chairman of the Board
Adam PascaleCFO/Chief Accounting Officer
See More
Hemispherx Biopharma, Inc. is a specialty pharmaceutical company engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. The company's proprietary drug technology uses specifically configu.....See More See More

Auditor: RSM US LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Ampligen
Alferon N Injection
BioPro Corp
BioAegean Corp
Hemispherx Biopharma Europe NV/SA
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: